Central line-associated blood stream infection during COVID-19 pandemic

Aldawood, Fatima; El-Saed, Aiman; Alzunitan, Mohammed; Alshamrani, Majid M.

doi:10.1016/j.jiph.2021.01.017

Cited by 8 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 25 Moreover, the excess use of immunosuppressive drugs such as tocilizumab and steroids among patients with COVOD-19 increased their susceptibility to infection including CLABSI. 9 , 26 Furthermore, as COVID-19 pandemic changed hospital admission policies with limited access to less severe cases, the increase of CLABSI rates could be due to the decrease in the denominator which is primarily composed of patients with lower CLABSI risk. 27 Furthermore, the preference of using the more-risky femoral catheter may have increased due to the fear of catheter insertion close to the mouth and respiratory secretions of the patients.…”

Section: Discussionmentioning

confidence: 99%

Impact of COVID-19 pandemic on the rates of central line...associated bloodstream infection and catheter-associated urinary tract infection in an.ßintensive care setting:.ßNational experience

Alsaffar

Alsheddi

Humayun

et al. 2023

American Journal of Infection Control

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impact of COVID-19 pandemic on the rates of central line...associated bloodstream infection and catheter-associated urinary tract infection in an.ßintensive care setting:.ßNational experience

Alsaffar

Alsheddi

Humayun

et al. 2023

American Journal of Infection Control

Self Cite

View full text Add to dashboard Cite

“…However, the remaining DAIs increased rather than decreased in 2020 [ 14 ]. In contrast, in a study which was conducted at the King Abdulaziz Medical City, Riyadh (KAMC-R), Kingdom of Saudi Arabia, the CLABSI rate was reported as high as 9.2/1000 central line days during the pandemic with zero CLABSI event in the pre-pandemic period [ 15 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Levels of Device-Associated Infections and Hand Hygiene Compliance

AlAhdal¹,

Alsada²,

AlRashed³

et al. 2022

Cureus

View full text Add to dashboard Cite

Background Healthcare-associated infections (HAIs) have been a major issue in intensive care units (ICUs), contributing to increased morbidity and mortality. They affect patients during the delivery of health care in hospitals where such infections were not present at the time of admission. Meanwhile, the course of coronavirus disease 2019 (COVID-19) may necessitate the transfer of critically ill patients to ICUs. Patients who need ICU services due to COVID-19 share similar underlying comorbidities, making them prone to microbiological infection. We aim to investigate the impact of the COVID-19 emergence period on device-associated infections (DAIs), the compliance of healthcare workers with hand hygiene, and other prevention bundles in ICU. Materials and methods This retrospective observational study analyzes secondary data from the infection control department in a single 500-bed hospital, including 80 adult ICU beds. DAI data from 2019, the pre-COVID-19 period, were compared to DAI data during the pandemic in 2020. In addition, prevention bundles and hand hygiene (HH) compliances for the same periods (before and after the COVID-19 pandemic) were compared. Results No significant impact was statistically detected in monthly and yearly comparisons of DAIs between 2019 and 2020. Similarly, HH compliance analysis revealed no significant difference between the two periods (p-value > 0.05). However, the data distribution for HH compliance displays a narrower range of measures. Nevertheless, only compliance with ventilator-associated pneumonia (VAP) prevention bundle of 2020 notably improved in comparison to 2019. Conclusion The impact of the COVID-19 pandemic was not evident over the DAIs. However, the compliance of healthcare workers to prevention bundles and HH in ICU was improved. Strict following and adherence to infection prevention and control (IPC) measures generally reduce the event of DAIs even on a non-significant scale.

show abstract

“…Entretanto, os indícios de favorecimento da colonização sistêmica por Candida spp. pelo uso desses medicamentos (PEMÁN et al, 2020;BISHBURG et al, 2021;ALDAWOOD et al, 2021;ANTINORI et al, 2020;SARI et al, 2021;RODRÍGUEZ et al, 2020) apontam para a necessidade de avaliar os riscos e benefícios dessa terapia de acordo com a situação clínica do paciente e dos níveis de contaminação nosocomial, especialmente por espécies do gênero Candida. A adequação terapêutica complica-se ainda mais quando se considera que os recursos laboratoriais avançados necessários para a identificação de Candida auris estão indisponíveis para a maior parte das unidades de saúde e que a terapia antifúngica preventiva pode ser ineficaz a depender dos fatores de resistência inerentes a cada cepa.…”

Section: Conclusõesunclassified